Immune checkpoint inhibitors in older adults with melanoma or cutaneous malignancies: The Wilmot Cancer Institute experience.

William J Archibald,Adrienne I Victor,Myla S Strawderman,Ronald J Maggiore

Journal of Geriatric Oncology（2020）

引用 27|浏览18

暂无评分

摘要

Anti-PD-1 monotherapy for older adults with cutaneous malignancies have similar response and irAE rates when compared to those of younger patients. Deaths from disease progression were more frequent than those from toxicity in both age subgroups.

查看译文

关键词

Melanoma,Merkel cell carcinoma,Immunotherapy,Immune related adverse events,Pembrolizumab,Nivolumab,Ipilimumab,Geriatric assessment,Older adult

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要